Adage Capital Partners Gp, L.L.C. Immunic, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Immunic, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,594,406 shares of IMUX stock, worth $6.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,594,406Holding current value
$6.04 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding IMUX
# of Institutions
68Shares Held
57.6MCall Options Held
600Put Options Held
254K-
Bvf Inc San Francisco, CA8.9MShares$9.62 Million0.35% of portfolio
-
Avidity Partners Management LP Dallas, TX8.9MShares$9.62 Million0.45% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.88 Million0.79% of portfolio
-
Janus Henderson Group PLC London, X06.99MShares$7.55 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY4.57MShares$4.93 Million0.1% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $33M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...